← Back to Clinical Trials
Recruiting NCT06235619

Arch Size Study for Anatomical Variations

Trial Parameters

Condition Aortic Arch
Sponsor IRCCS San Raffaele
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 0 Years
Max Age 100 Years
Start Date 2024-09-01
Completion 2025-12-01

Brief Summary

The aortic arch with a common origin of the innominate and left carotid artery (CILCA) prevalence in the general population is 13.6%. Its reputation as a benign anatomical variant has been ultimately shattered by further studies that identified the CILCA arch as a potential marker for thoracic aortic disease (TAD) The aim of this work is to report the CT anatomical characteristics of the aortic arch in subjects with or without aneurysms requiring treatment, in 5 major European cardiovascular centers.

Eligibility Criteria

Inclusion Criteria: all patients with aortic arch CT scan at investigating centers Exclusion Criteria: none

Related Trials